Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to Iovance Biotherapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 1c

May 10, 2018 4:28 PM EDT

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.31), $0.01 worse than the analyst estimate of ($0.30).

Our January 2018 financing puts us in a strong position to advance and expand our robust TIL product pipeline. We continue enrollment in our ongoing trials and have expanded our... More